2 Results Sort by:
Membrane-anchored Fusokine as Vaccine Adjuvant to Prevent Viral Infection
Application GIFT4 anchored to virus-like particles (VLPs) as a prophylactic vaccine adjuvant to prevent chronic viral infections including HIV, HBV, HPV and influenza. Key Benefits GIFT4-containing VLPs induce higher antibody response than non-adjuvanted VLPs. Effectively induce strong mucosal immune response. Market Summary Currently, there...
Published: 11/27/2023       Contributor(s): Baozhong Wang, Richard Compans, Jacques Galipeau, Jiusheng Deng
GIFT4: GM-CSF and IL-4 Fusion Protein for Treating Cancer and Infectious Diseases
Application A recombinant fusion cytokine that activates host immune responses for the treatment of cancer or infectious diseases and the development of adjuvant vaccines. Key Benefits Retains the immune stimulatory properties of both its parental molecules. Displays novel functions such as direct activation of B cells leading to anti-cancer and...
Published: 3/11/2024       Contributor(s): Jacques Galipeau, Jiusheng Deng